Literature DB >> 14463517

Critical relationships between constituents of the antigen-adjuvant emulsion affecting experimental allergic encephalomyelitis in a completely susceptible mouse genotype.

J M LEE, H A SCHNEIDER.   

Abstract

The production of EAE in the fully susceptible BSVS mouse genotype has been found to be dependent on the ratio of proteolipid antigen and adjuvant mycobacterial concentration as used in the emulsion, of the Freund type. Disturbance of this ratio, by manipulation of either component, by diminution or increase, results in a decrease in the frequency by which EAE is produced. Simultaneous reduction of antigen and mycobacteria, so that the ratio remains unchanged, retains the full EAE-producing power of the emulsion. The limit of this has not been ascertained. Emulsifying agents have been found to restrict further the permissible limits of the antigen-mycobacterial ratio for full EAE production. Such effects of the emulsifier have been found to vary with the qualitative nature of the emulsifier. Aquaphor has been found to be less restrictive than falba. These phenomena, systematically analyzed here for the mouse, may have an application for other antigen-adjuvant systems and for other hosts.

Entities:  

Keywords:  ENCEPHALOMYELITIS/experimental

Mesh:

Substances:

Year:  1962        PMID: 14463517      PMCID: PMC2137478          DOI: 10.1084/jem.115.1.157

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Clinico-pathologic correlations in experimental allergic encephalomyelitis. II. Development of an index for quantitative assay of encephalitogenic activity of antigens.

Authors:  E C ALVORD; M W KIES
Journal:  J Neuropathol Exp Neurol       Date:  1959-07       Impact factor: 3.685

2.  Simple method for enhancing development of acute disseminated encephalomyelitis in mice.

Authors:  J M LEE; P K OLITSKY
Journal:  Proc Soc Exp Biol Med       Date:  1955-06

3.  Experimental allergic encephalomyelitis after the excision of the injection site of antigen-adjuvant emulsion.

Authors:  J FREUND; M M LIPTON
Journal:  J Immunol       Date:  1955-12       Impact factor: 5.422

4.  Role of heredity in experimental disseminated encephalomyelitis in mice.

Authors:  J M LEE; P K OLITSKY; H A SCHNEIDER; N D ZINDER
Journal:  Proc Soc Exp Biol Med       Date:  1954-03

5.  Proteolipides, a new type of tissue lipoproteins; their isolation from brain.

Authors:  J FOLCH; M LEES
Journal:  J Biol Chem       Date:  1951-08       Impact factor: 5.157

6.  The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review.

Authors:  J FREUND
Journal:  Am J Clin Pathol       Date:  1951-07       Impact factor: 2.493

7.  Rapid induction of allergic encephalomyelitis in rats without the use of mycobacteria.

Authors:  J BELL; P Y PATERSON
Journal:  Science       Date:  1960-05-13       Impact factor: 47.728

8.  Suppression of experimental "allergic" encephalomyelitis in guinea pigs by encephalitogenic proteins extracted from homologous brain.

Authors:  C M SHAW; W J FAHLBERG; M W KIES; E C ALVORD
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307

  8 in total
  12 in total

1.  Adjuvant-antigen relationships in the production of experimental "allergic" encephalomyelitis in the guinea pig.

Authors:  C M SHAW; E C ALVORD; W J FAHLBERG; M W KIES
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

2.  Formalin-Treated Foot-and-Mouth Disease Virus: Comparison of Two Adjuvants in Cattle.

Authors:  H R Cunliffe; J H Graves
Journal:  Can J Comp Med Vet Sci       Date:  1963-08

3.  [Experimental allergic chorioretinitis in rabbits by immunization to homologous retina in adjuvant. I. Clinical studies (author's transl)].

Authors:  K D Schröder; W Meyer; E Hempel; S Tilgner
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1974

4.  Immunohistological evidence of perivascular localization of basic protein in early development of experimental allergic encephalomyelitis.

Authors:  J Simon; A P Anzil
Journal:  Acta Neuropathol       Date:  1974-02-07       Impact factor: 17.088

5.  Immunization of BSVS mice with heterologous and homologous adrenal gland.

Authors:  O Werdelin; D H Boehme
Journal:  Immunology       Date:  1969-02       Impact factor: 7.397

6.  Relationship between the incidence of experimental allergic encephalomyelitis and the development of adjuvant disease.

Authors:  N Allegretti; B Vitale
Journal:  Immunology       Date:  1965-07       Impact factor: 7.397

7.  Murine thyroiditis. 3. Influence of syngeneic and allogeneic thyroid antigen on induction of the disease.

Authors:  A O Vladutiu; N R Rose
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

8.  Adjuvanticity and delayed-type hypersensitivity by Bacillus Calmette-Guérin (BCG).

Authors:  I J Hiu; J L Amiel
Journal:  Experientia       Date:  1972-08-15

9.  Prevention of experimental allergic encephalomyelitis (EAE) by vitamin C deprivation.

Authors:  P S MUELLER; M W KIES; E C ALVORD; C M SHAW
Journal:  J Exp Med       Date:  1962-02-01       Impact factor: 14.307

10.  Antibody studies in rabbit encephalomyelitis induced by a water-soluble protein fraction of rabbit cord.

Authors:  R F KIBLER; A E BARNES
Journal:  J Exp Med       Date:  1962-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.